Home » Newsletters » BioWorld

BioWorld

Nov. 30, 2009

View Archived Issues

Strong at the Broken Places: Models for Industry's Future

There's a lot of talk these days about how the biotech industry's business models are broken. Read More

Money Raised Year to Date

Tetchy HCV Sector Sleepy Over InterMune; Revival Due in 2010?

Money Raised By Biotech in 2009

Week in Review

Word on the Street

Week in Washington

Collaborations Between Biotech And Pharmaceutical Companies: Oct. 1 - Nov. 24, 2009

Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Oct. 1 - Nov. 24, 2009

Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, Oct. 1 - Nov. 24, 2009

Stock Gainers and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...